Atlas Trials

Safety and Efficacy of PRO-157 vs Moxifloxacin vs Gatifloxacin in Patients With Bacterial Conjunctivitis (Pazufloxacin)

Clinical trial NCT02980523 · COMPLETED

Trial details

NCT number
NCT02980523
Sponsor
Laboratorios Sophia S.A de C.V.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Bacterial Conjunctivitis
Start date
2015-03-01
Primary completion
2016-06-01
Enrollment
150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.